Abstract: The assessment of urban quality of life (UQoL) is a multidimensional challenge involving socioeconomic, environmental, and infrastructure-related variables that, due to changes in the ...

LONDON--(BUSINESS WIRE)--$SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA ...

During his remarks in a cabinet meeting this month, President Trump refused to answer a reporter's question on "phase two" of his Gaza peace deal. Trump stated, "I'm not going to talk about that." 'No ...

Abstract: This paper investigates the self-calibration of gain-phase errors in Uniform Linear Arrays (ULA). Traditional methods that exploit the Toeplitz structure of the signal covariance matrix ...

The relentless pursuit of innovative treatments in the pharmaceutical industry continues to reshape the landscape of chronic disease management. Merck & Co. Inc. (NYSE:MRK) on Wednesday announced ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ...

Tvardi Therapeutics has failed its first big test as a public company. Months after joining the Nasdaq, the biotech has reported the unappetizing mix of high dropout rates and placebolike efficacy in ...

This issue of the Anais da Academia Brasileira de Ciências (AABC) is very special since, for the first time, this journal has published over 1000 pages in a year. There are 29 articles that cover ...